# Citius Pharmaceuticals, Inc.: Form 8-K, filed May 30, 2025

- Company: [Citius Pharmaceuticals, Inc.](/companies/ctxr.md) (CIK 1506251)
- Form: 8-K
- Filed: 2025-05-30
- Accepted by EDGAR: May 30, 2025, 17:15 ET
- Period: 2025-05-29
- Accession: 0001213900-25-049550
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1506251/000121390025049550/ea0244023-8k_citius.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1506251/000121390025049550/

## Items reported

- Item 3.01: Delisting notice

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1506251/000121390025049550/ea0244023-8k_citius.htm

Filed May 30, 2025.
Source: SEC EDGAR, the filing index for accession 0001213900-25-049550. Last ingested by Listed: Nov 4, 2026, 17:46 ET. No prices; not investment advice.